Guideline on the use of new anticancer drugs for the treatment of Hepatocellular Carcinoma 2010 update-Reference-Cited by-同舟云学术

Guideline on the use of new anticancer drugs for the treatment of Hepatocellular Carcinoma 2010 update

Published:2012-05-08 Issue:6 Volume:42 Page:523-542
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:

Author:

Kaneko Shuichi,Furuse Junji,Kudo Masatoshi,Ikeda Kenji,Honda Masao,Nakamoto Yasunari,Onchi Morikazu,Shiota Goshi,Yokosuka Osamu,Sakaida Isao,Takehara Tetsuo,Ueno Yoshiyuki,Hiroishi Kazumasa,Nishiguchi Shuhei,Moriwaki Hisataka,Yamamoto Kazuhide,Sata Michio,Obi Shuntaro,Miyayama Shiro,Imai Yukinori

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Reference35 articles.

1. Sorafenib in advanced hepatocellular carcinoma;Llovet;N Engl J Med,2008

2. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial;Cheng;Lancet Oncol,2009

3. Nexavar® adverse reaction reports liver injury and interstitial pulmonary disease (Japanese) 2010

4. Phase II study of sorafenib in patients with advanced hepatocellular carcinoma;Abou-Alfa;J Clin Oncol,2006

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Importance of Regimens in Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma with Macrovascular Invasion;Cancers;2021-09-03

2. Serum-derived exosomes function as tumor antigens in patients with advanced hepatocellular carcinoma;Molecular Immunology;2021-06

3. Therapeutic efficacy of lenvatinib for patients with unresectable hepatocellular carcinoma based on the middle-term outcome;PLOS ONE;2020-04-10

4. The efficacy of sorafenib in preventing hepatocellular carcinoma recurrence after resection: a systematic review and meta-analysis;Revista Española de Enfermedades Digestivas;2020

5. Increased Arterio-Portal Shunt Formation after Drug-Eluting Beads TACE for Hepatocellular Carcinoma;Oncology;2020